Psoriasis: Interleukin-17A-Inhibitor erhöht Therapiezufriedenheit
Crossref DOI link: https://doi.org/10.1007/s15012-023-8342-z
Published Online: 2024-01-23
Published Print: 2024-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schroeder, Ingo
Text and Data Mining valid from 2024-01-01
Version of Record valid from 2024-01-01
Article History
First Online: 23 January 2024
Free to read: This content has been made available to all.